| name | Mometasone Furoate 0.1% |
| classification | Topical corticosteroid |
| pharmacokinetics | Mometasone furoate is a potent topical corticosteroid that is absorbed through the skin. Peak concentrations are achieved within hours of application. The drug is primarily metabolized in the liver and eliminated via the kidneys and feces. The exact pharmacokinetic profile in a 25-year-old male weighing 70kg is not specific for this particular dose and formulation, and would need to be determined from clinical studies focused on that specific patient group. |
| suggested dosage | Dosage is dependent on the specific indication. Consult a physician for proper guidance. 0.1% mometasone furoate is typically applied topically to the affected area once or twice daily. The amount of application area and overall required daily dose should be determined by a physician based on the patient's specific needs and clinical presentation. |
| indications | Mometasone furoate 0.1% cream is used topically for the treatment of inflammatory skin conditions, such as mild to moderate eczema, psoriasis, and allergic contact dermatitis. It may be used for the treatment of other skin conditions after consideration by a qualified physician. |
| safety in pregnancy | Limited data on use in pregnancy, especially in the first trimester. Potentially associated with some risks, but specific risk for the patient in question is unknown. Always consult a physician for personalized guidance. |
| safety in breastfeeding | Limited data is available. Some small amounts of the medication may be absorbed into the bloodstream, and could potentially be secreted in breast milk. It is important to assess the potential benefits versus risks and consult with a physician for informed decision making. |
| side effects | | 1 | Skin irritation | | 2 | Burning sensation | | 3 | Skin atrophy (thinning of the skin) | | 4 | Striae (stretch marks) | | 5 | Skin discoloration | | 6 | Hirsutism (excessive hair growth in areas where it shouldn't grow) | | 7 | Telangiectasia (visible small blood vessels) | | 8 | Systemic effects (if absorbed in excess) such as adrenal suppression | | 9 | Infection at the application site |
|
| alternatives | |
| contraindications | | 1 | Known hypersensitivity or allergy to mometasone furoate or any of the inactive ingredients | | 2 | Active skin infection or lesions at the application site | | 3 | Use over large areas of the skin for prolonged periods | | 4 | Use on the face of children in the first few years of life |
|
| interactions | Limited interactions are documented in the literature. Interactions with other topical or systemic medications should be discussed with a physician before use. |
| warnings and precautions | | 1 | Do not use on broken skin or open wounds. | | 2 | Avoid contact with eyes. | | 3 | Discontinue use and consult a physician if irritation worsens. | | 4 | Do not use for prolonged periods or over large surface areas without physician supervision. | | 5 | Monitor for signs of skin atrophy (thinning of the skin). |
|
| additional informations | This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for accurate diagnosis, appropriate treatment recommendations, and personalized care plans. |
| patient data | |
